COVID-19 Original ArticleComparative immunogenicity analysis of intradermal versus intramuscular administration of SARS-CoV-2 RBD epitope peptide-based immunogen In vivo
Under an Elsevier user license
open archive
Keywords
SARS-COV-2
Intradermal immunization
Vaccine
RBD peptide
Humoral and cellular responses
Abbreviations
RBD
Receptor binding protein
ID
Intradermal
IM
Intramuscular
hACE2
human-angiotensin-converting enzyme 2
COVID-19
Coronavirus disease 2019
SARS-CoV-2
Severe acute respiratory syndrome-related Coronavirus 2
MERS-CoV
Middle East respiratory syndrome Coronavirus
SARS-CoV
Severe acute respiratory syndrome-related Coronavirus
S protein
Spike protein
TMB
3,3',5,5'-Tetramethylbenzidine
ELISA
Enzyme-Linked Immunosorbent Assay
Cited by (0)
- 1
Equal contribution.
© 2021 Institut Pasteur. Published by Elsevier Masson SAS.